Clinical Trial Update: A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study comparing BIOD 531 to Humalog Mix 75/25 for Type 2 diabetes has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BIOD 531
• Humalog Mix 75/25 (insulin lispro protamine suspension and insulin lispro)

Snippet

Sponsor: Biodel | Conditions: Diabetes Mellitus | Phase 2 | Status: SUSPENDED